Cosentyx 150 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F6W9U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,223
Award facts
- Contract value 100% obligated
- $11,222.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,222.76 to AmerisourceBergen Drug Corp for COSENTYX 150 mg/ml syringes on January 13, 2026, with an ultimate completion date of January 14, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating open and competitive procurement. The place of performance is in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. COSENTYX is a specialty biologic medication used in the treatment of inflammatory conditions, reflecting the company's role in supplying critical medications across multiple therapeutic domains to Defense Health Agency customers and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F6W9U?
SPE2DR26F6W9U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F6W9U worth?
The government has obligated $11,223 on SPE2DR26F6W9U.
Is contract SPE2DR26F6W9U an order under another contract?
Yes. SPE2DR26F6W9U is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6W9U competed?
The extent of competition for SPE2DR26F6W9U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award